Solubility improvement of drugs using N-methyl pyrrolidone

被引:124
作者
Sanghvi, Ritesh [1 ]
Narazaki, Ryuichi [2 ]
Machatha, Stephen G. [3 ]
Yalkowsky, Samuel H. [1 ]
机构
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[2] Eisai & Co Ltd, Formulat Res Lab, Gifu 5016195, Japan
[3] Cydex Inc, Lenexa, KS 66214 USA
关键词
complexing agent; cosolvent; N-methyl pyrrolidone; solubility enhancement;
D O I
10.1208/s12249-008-9050-z
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The solubilization efficiency of N-methyl pyrrolidone (NMP) has been determined and compared to that of ethanol and propylene glycol for 13 poorly soluble drugs. NMP is found to be a more efficient solubilizer for all the drugs studied. The solubility enhancement as high as about 800-fold is obtained in 20% v/v NMP solution as compared to water. The mechanism of drug solubilization by NMP has also been investigated. It is proposed that NMP enhances drug solubility by simultaneously acting as a cosolvent and a complexing agent. A mathematical model is used to estimate the drug solubility in NMP-water mixture, according to which the total solubility enhancement is a sum of the two effects. This model describes the experimental data well and is more accurate than other models. A large and uniform reduction in the surface tension of water as a function of NMP concentration demonstrates its cosolvent effect. The complexation is supported by the fact that it's strength is affected by the temperature and the polarity of the medium. A strong correlation exists between log K-ow of the drugs and the cosolvency coefficients. The correlation between log K-ow and the complexation coefficients is weak suggesting that factors such as molecular shape and aromaticity of the drug molecule are significant in determining the complexation strength. This has been confirmed by the absence of a significant complexation between NMP and linear drug-like solutes.
引用
收藏
页码:366 / 376
页数:11
相关论文
共 20 条
[1]
AGUIAR A J, 1987, Journal of Controlled Release, V6, P375, DOI 10.1016/0168-3659(87)90091-5
[2]
BARTSCH W, 1976, ARZNEIMITTEL-FORSCH, V26, P1581
[3]
HILDEBRAND JH, 1929, J AM CHEM SOC, V49, P1
[4]
Solubilization of poorly soluble compounds using 2-pyrrolidone [J].
Jain, Parijat ;
Yalkowsky, Samuel H. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 342 (1-2) :1-5
[5]
SOLVENT EFFECTS ON CHEMICAL PROCESSES .1. SOLUBILITY OF AROMATIC AND HETEROCYCLIC-COMPOUNDS IN BINARY AQUEOUS ORGANIC-SOLVENTS [J].
KHOSSRAVI, D ;
CONNORS, KA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (04) :371-379
[6]
Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport [J].
Lee, PJ ;
Langer, R ;
Shastri, VP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (04) :912-917
[7]
SOLUBILITY OF ORGANIC SOLUTES IN ETHANOL-WATER MIXTURES [J].
LI, A ;
YALKOWSKY, SH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (12) :1735-1740
[8]
Bilinear model for the prediction of drug solubility in ethanol/water mixtures [J].
Machatha, SG ;
Yalkowsky, SH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (12) :2731-2734
[9]
Physical properties of aqueous N-methyl pyrrolidone at different temperatures [J].
Maloka, IE ;
Ibrahim, SY .
PETROLEUM SCIENCE AND TECHNOLOGY, 2004, 22 (11-12) :1571-1579
[10]
EXTENDED HILDEBRAND SOLUBILITY APPROACH - METHYLXANTHINES IN MIXED-SOLVENTS [J].
MARTIN, A ;
PARUTA, AN ;
ADJEI, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (10) :1115-1120